Zonghui Ma

8PUBLICATIONS
4CO-AUTHORS
AutoimmunityMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 17, 2025
Orally Bioavailable BRD4 BD1 Inhibitor ZL0516 Effectively Suppresses Colonic Inflammation in Animal Models of Inflammatory Bowel Disease.

Zonghui Ma, Steven McAninch, Zhiqing Liu

|Mar 26, 2025
Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach.

Zonghui Ma, Mingxiang Zhou, Haiying Chen

|Sep 02, 2024
An updated patent review of BRD4 degraders.

Zonghui Ma, Cun Zhang, Andrew A Bolinger

|Jan 30, 2023
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to inspire epigenetic therapeutics.

Zonghui Ma, Andrew A Bolinger, Jia Zhou

Pageof 2